Kumar Neil 的 Form 4 申報
BridgeBio Pharma, Inc.（BBIO），2026/4/13 申報
- 申報編號
- 0001470831-26-000361
- 申報時間
- 2026/4/13
- 交易日
- 2026/4/9-4/10
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 8 筆非衍生性交易。公開市場賣出合計 $596.9 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kumar NeilCIK 0001742485 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/4/9 | Common Stock | S賣出處分 | −7,200 | $73.64F2 | −$530,208 | 628,486 | 間接 | |
| 2026/4/9 | Common Stock | S賣出處分 | −5,300 | $74.60F4 | −$395,380 | 623,186 | 間接 | |
| 2026/4/9 | Common Stock | S賣出處分 | −7,500 | $75.55F5 | −$566,625 | 615,686 | 間接 | |
| 2026/4/9 | Common Stock | S賣出處分 | −7,072 | $73.64F6 | −$520,782.08 | 4,431,375 | 間接 | |
| 2026/4/9 | Common Stock | S賣出處分 | −5,128 | $74.57F7 | −$382,394.96 | 4,426,247 | 間接 | |
| 2026/4/9 | Common Stock | S賣出處分 | −7,800 | $75.53F8 | −$589,134 | 4,418,447 | 間接 | |
| 2026/4/10 | Common Stock | S賣出處分 | −20,000 | $74.60F9 | −$1,492,000 | 595,686 | 間接 | |
| 2026/4/10 | Common Stock | S賣出處分 | −20,000 | $74.60F10 | −$1,492,000 | 4,398,447 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average sale price of the shares sold from $73.19 to $74.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of the shares sold from $74.19 to $75.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents the weighted average sale price of the shares sold from $75.22 to $76.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of the shares sold from $73.15 to $74.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents the weighted average sale price of the shares sold from $74.18 to $75.145 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents the weighted average sale price of the shares sold from $75.18 to $76.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents the weighted average sale price of the shares sold from $74.26 to $75.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents the weighted average sale price of the shares sold from $74.27 to $75.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。